FANH vs. GOCO, EHTH, SLQT, RDZN, PDLB, LCNB, TSBK, OPAD, TDF, and BWFG
Should you be buying Fanhua stock or one of its competitors? The main competitors of Fanhua include GoHealth (GOCO), eHealth (EHTH), SelectQuote (SLQT), Roadzen (RDZN), Ponce Financial Group (PDLB), LCNB (LCNB), Timberland Bancorp (TSBK), Offerpad Solutions (OPAD), Templeton Dragon Fund (TDF), and Bankwell Financial Group (BWFG). These companies are all part of the "finance" sector.
Fanhua (NASDAQ:FANH) and GoHealth (NASDAQ:GOCO) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and community ranking.
Fanhua received 194 more outperform votes than GoHealth when rated by MarketBeat users. Likewise, 54.69% of users gave Fanhua an outperform vote while only 53.42% of users gave GoHealth an outperform vote.
Fanhua has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500. Comparatively, GoHealth has a beta of 1.79, indicating that its stock price is 79% more volatile than the S&P 500.
Fanhua has a net margin of 8.67% compared to GoHealth's net margin of -8.61%. Fanhua's return on equity of 12.11% beat GoHealth's return on equity.
In the previous week, Fanhua had 2 more articles in the media than GoHealth. MarketBeat recorded 2 mentions for Fanhua and 0 mentions for GoHealth. Fanhua's average media sentiment score of 0.85 beat GoHealth's score of 0.00 indicating that Fanhua is being referred to more favorably in the media.
26.7% of Fanhua shares are owned by institutional investors. Comparatively, 24.2% of GoHealth shares are owned by institutional investors. 25.6% of Fanhua shares are owned by company insiders. Comparatively, 52.0% of GoHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Fanhua has higher earnings, but lower revenue than GoHealth. GoHealth is trading at a lower price-to-earnings ratio than Fanhua, indicating that it is currently the more affordable of the two stocks.
GoHealth has a consensus price target of $13.00, suggesting a potential upside of 29.87%. Given GoHealth's higher possible upside, analysts plainly believe GoHealth is more favorable than Fanhua.
Summary
Fanhua beats GoHealth on 12 of the 16 factors compared between the two stocks.
Get Fanhua News Delivered to You Automatically
Sign up to receive the latest news and ratings for FANH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FANH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
